Project Number 5R01AG063817-02 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Engineering Anti-Tau Intrabodies that Reduce Tauopathy by Either the Proteasome; Lysosome; or Chaperone Mediated Autophagy Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau b. Tau Phosphorylation, Metabolism, and Assembly Researcher and Organization Principal Investigator GALLARDO, GILBERT Principal Investigator First Name GILBERT Principal Investigator Last Name GALLARDO Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-484: NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) FY Overall Cost $393,541 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YANG, AUSTIN JYAN-YU
